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Coronins are a conserved family of WD repeat-contain-
ing, actin-binding proteins that regulate cell motility in a
variety of model organisms. Our results show that Coro-
nin 1B is a ubiquitously expressed member of the mam-
malian Coronin gene family that co-localizes with the
Arp2/3 complex at the leading edge of fibroblasts, and
co-immunoprecipitates with this complex. Pharmacolog-
ical experiments show that the interaction between Coro-
nin 1B and the Arp2/3 complex is regulated by protein
kinase C (PKC) phosphorylation. Coronin 1B is phospho-
rylated by PKC both in vitro and in vivo. Using tryptic
peptide mapping and mutagenesis, we have identified
serine 2 (Ser-2) on Coronin 1B as the major residue phos-
phorylated by PKC in vivo. Rat2 fibroblasts expressing
the Coronin 1B S2A mutant show enhanced ruffling in
response to phorbol 12-myristate 13-acetate (PMA) and
increased speed in single cell tracking assays. Cells ex-
pressing the Coronin 1B S2D mutant have attenuated
PMA-induced ruffling and slower cell speed. Expression
of the S2A mutant partially protects cells from the inhib-
itory effects of PMA on cell speed, whereas expression of
the S2D mutant renders cells hypersensitive to its effects.
These data demonstrate that Coronin 1B regulates lead-
ing edge dynamics and cell motility in fibroblasts, and
that its ability to control motility and interactions with
the Arp2/3 complex are regulated by PKC phosphoryla-
tion at Ser-2. Furthermore, Coronin 1B phosphorylation
is responsible for a significant fraction of the effects of
PMA on fibroblast motility.
The dynamic re-organization of the actin cytoskeleton is
required for many processes including migration, endocytosis,
and intracellular junction formation. Coronins are a conserved
family of WD repeat-containing, actin-binding proteins that
regulate migration and other actin-dependent processes in
model organisms. Mammalian genomes contain at least six
Coronin genes, however, little is known about the molecular
function or regulation of Coronins in mammalian cell motility.
The founding member of the Coronin protein family was
discovered in Dictyostelium as an F-actin-binding protein pres-
ent in a contracted myosin-actin preparation (1). Subsequent
gene knock-out studies showed that this protein was involved
in cell motility and cytokinesis (2). Dictyostelium cells deficient
in Coronin move at about half the rate of the wild-type controls
and have a high frequency of failed cytokinesis. The protein is
localized at the leading edge of motile cells. In addition to
motility defects, Coronin null cells also have strong defects in
fluid phase endocytosis (3).
Yeast also has a Coronin protein that binds to F-actin in vitro
and localizes in vivo to dynamic actin structures such as actin
patches (4, 5). Unlike Dictyostelium, disruption of the single
Coronin gene (CRN1) in yeast does not lead to gross defects in
growth or cytoskeletal organization. However, when a crn1
mutation is combined with a mutation in the gene encoding
Cofilin (cof1–22), a protein involved in actin filament turnover,
synthetic defects in growth and cytoskeletal organization are
observed (5). Overexpression of Coronin in yeast induces the
formation of aberrant actin loops and causes lethality (6). Pu-
rified yeast Coronin binds directly to the Arp2/3 complex via its
coiled-coil domain and inhibits Arp2/3-mediated actin nucle-
ation in vitro. In support of these in vitro studies, mutations in
the CRN1 gene genetically synergize with mutations in the
subunits of the Arp2/3 complex.
Coronin has also been studied in other model organisms. In
Drosophila, mutations in Coronin cause disruptions in the ac-
tin cytoskeleton of the embryonic imaginal disks and an early
pupal lethal phenotype, indicating that this gene is essential
for morphogenesis in this organism (7). In Xenopus, Coronin
localizes to the periphery of fibroblastic cells and, like Dictyoste-
lium and yeast Coronins, co-sediments with F-actin in vitro (8).
Also, the coiled-coil region at the C terminus of Xenopus Coronin
has been shown to mediate oligomerization (9). Expression of a
putative dominant negative construct containing the five canon-
ical WD repeats from Xenopus Coronin leads to defects in cell
spreading and Rac-induced lamellipodial formation (8).
Several mammalian members of the Coronin family have
been described (10). For clarity, we have adopted the Human
Genome Organization (HUGO) nomenclature for mammalian
Coronin genes (www.gene.ucl.ac.uk/nomenclature/genefamily/
coronin.html). Coronin 1A (also known as p57 or Coronin-1)
was the first Coronin to be identified in mammals and is highly
expressed in cells of the hematopoietic lineage as well as parts
of the nervous system (11). This protein is a substrate for PKC
both in vitro and in vivo; however, the sites that are phospho-
rylated are unknown and the functional significance of phos-
phorylation has not been well characterized (12). Coronin 1B
(also known as CoroninSE or Coronin-2) was discovered as a
carbachol-stimulated phosphoprotein in rabbit parietal cells
(13). Carbachol acts via a protein kinase C (PKC)1 pathway in
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this cell type to regulate secretion. Recently, this gene was
identified in a microarray-based screen for genes up-regulated
in a neural regeneration model (14). Overexpression of Coronin
1B induced neurite extension in several neuronal cell lines,
whereas reduced expression via RNA interference caused a
reduction in outgrowth. Two-dimensional gel electrophoresis
studies suggest that Coronin 1C (Coronin-3) is also phospho-
rylated in vivo (15).
The potential PKC regulation of mammalian Coronins is
intriguing because this family of Ser/Thr kinases regulates
migration in many cell types. Activation of classic and novel
isoforms of PKC by the phorbol ester phorbol 12-myristate
13-acetate (PMA) in some cell types increases cell migration,
whereas in other cell types, it is inhibitory (16). These opposing
effects are likely because of the complement of PKC isoforms
and/or substrate proteins expressed in a given cell type (17).
PMA is thought to exert its effects on migration by changing
adhesiveness and/or actin architecture at the leading edge (18,
19). PMA also regulates other actin-based motility events such
as neurite outgrowth and endosome rocketing (20, 21). Despite
the clear importance of PKC in cell motility, a relatively small
number of PKC substrate proteins have been thoroughly char-
acterized in terms of the residues phosphorylated and func-
tional significance of their phosphorylation in the control of
motility. In this work, we have identified serine 2 as the major
in vivo PKC phosphorylation site on Coronin 1B, and demon-
strate that phosphorylation regulates the interaction between
Coronin 1B and the Arp2/3 complex. Furthermore, we show
that Ser-2 phosphorylation of Coronin 1B regulates PMA-in-
duced ruffling and cell migration.
EXPERIMENTAL PROCEDURES
Materials—Commercial antibodies were obtained from Cell Signal-
ing Technologies (pSerPKC), Upstate Biotechnology (p34-Arc), Roche
(GFP), and Sigma (9E10/Myc). Alexa Fluor 568 phalloidin was from
Molecular Probes. Cell lines were from ATCC. PKC inhibitors Ro32-
0432 and Gö6976 were from Calbiochem. Protease and phosphatase
inhibitors (phenylmethylsulfonyl fluoride, 1,10-phenanthroline, aproti-
nin, leupeptin, sodium fluoride, and sodium orthovanadate) were from
Sigma. All other materials were from Fisher Scientific unless otherwise
indicated.
TaqMan Quantitative Real-time PCR—Total RNA was isolated from
murine tissues using a Qiagen RNeasy Isolation kit according to the
manufacturer’s protocol. Reverse transcription into cDNA was done in
a 20-l volume using oligo(dT)12–18 Primer, 10 mM dNTP mixture, and
Improm-II Reverse Transcriptase (Promega) according to the manufac-
turer’s instructions. PCR were carried out in a 20-l volume consisting
of 10 l of Universal Master Mix No AmpErase UNG (Applied Biosys-
tems), 0.25 g of fluorogenic probe (Mm00486998_m1[1A],
Mm00488552_g1[1B], Mm00488558_m1[1C], Mm00619135_m1[2A],
Mm00558512_m1[2B], Mm00504152_m1[POD], Applied Biosystems),
and 8 l of diluted cDNA (80 ng of total RNA/reaction). The PCRs
were carried out under standard conditions in a 20-l volume in dupli-
cate for each sample in the ABI Prism 7700 Sequence Detection System
(Applied Biosystems). The number of PCR cycles needed to reach the
fluorescence threshold was determined in duplicate for each cDNA,
averaged, and then normalized against a reference gene, 18 S
(4333760–0311007 Applied Biosystems), to yield the cycle number at
which fluorescence was reached (Ct). For the absolute copy number of
Coronin 1A, 1B, 1C, 2A, 2B, and POD, 4-fold dilutions of the respective
mouse full-length cDNAs were used to generate a standard curve (22).
All tissue samples tested were within the linear range (19–38 cycles) of
the assay.
Molecular Cloning—PCR and subcloning were performed using stand-
ard methods. Detailed methods and primer sequences are available upon
request. WT1B-EGFP was constructed by amplifying the coding sequence
of human Coronin 1B and cloning it into a pMSCV-based retroviral vector
(23). S2A-EGFP and S2D-EGFP were generated from WT1B-EGFP by
site-directed mutagenesis using mutation-encoding primers. Coronin 1B-
Myc was generated by subcloning the Coronin 1B coding sequence into a
pMSCV vector containing a C-terminal Myc tag.
Cell Culture, Transient Transfection, and Retroviral Transduction—
HEK293 and Swiss 3T3 cells were cultured in Dulbecco’s modified
Eagle’s medium-H supplemented with 10% fetal bovine serum (Hy-
Clone), 100 units/ml penicillin, 100 g/ml streptomycin, and 292 g/ml
glutamine. Rat2 and NIH3T3 cells were cultured in the same media
supplemented with 5% fetal bovine serum or 10% calf serum (HyClone),
respectively. HEK293 cells were transiently transfected with plasmids
using FuGENE 6 transfection reagent (Roche) according to the manu-
facturer’s protocol. Retroviral packaging, infections, and fluorescence-
activated cell sorting were performed as described previously (23).
Immunoprecipitation—Cells were washed twice with phosphate-
buffered saline and lysed with a KCl buffer (20 mM HEPES, pH 7.0, 100
mM KCl, 0.5% Nonidet P-40, 1 mM EDTA, 1 mM phenylmethylsulfonyl
fluoride, 10 g/ml 1,10-phenanthroline, 10 g/ml aprotinin, 10 g/ml
leupeptin, 10 mM sodium fluoride, and 2 mM sodium orthovanadate).
Lysates were cleared at 13,000  g for 5 min and incubated with 0.5 g
of primary antibody for 1 h at 4 °C, followed by the addition of 20 l of
50% slurry of ImmunoPure-immobilized protein A/G beads (Pierce) and
further incubation at 4 °C for an additional hour. Beads were pre-
blocked with 1 mg/ml bovine serum albumin and washed extensively
with the KCl buffer prior of usage. The immune complexes were col-
lected, washed with the KCl buffer three times, separated by SDS-
PAGE, and transferred to a polyvinylidene difluoride membrane (Bio-
Rad) for Western blotting.
Recombinant Protein Production—His6-tagged Coronin 1B (His1B)
was generated by PCR cloning the coding sequence of human Coronin
1B into pQE-80L (Qiagen). GST-tagged full-length (GST1B) or the
C-terminal fragment of Coronin 1B were cloned by PCR into pGEX-6P1
(Amersham Biosciences). For protein production, cells were grown to
mid-log and expression was induced with 0.5 mM isopropyl 1-thio--D-
galactopyranoside for 6 h at room temperature. Bacteria was harvested
and sonicated in lysis buffer (50 mM HEPES, pH 7.4, 0.5% Triton X-100,
0.5 M NaCl, 5 mM 2-mercaptoethanol, 1 mM phenylmethylsulfonyl flu-
oride, 10 g/ml 1,10-phenanthroline, 10 g/ml aprotinin, 10 g/ml
leupeptin, and 10 mM imidazole). His1B was purified by affinity chro-
matography using nickel-chelated agarose (Pierce). Lysate, cleared at
20,000  g for 20 min, was applied to a nickel-chelated agarose column,
and washed using the lysis buffer containing 40 mM imidazole. His1B
was eluted with 500 mM imidazole in 50 mM HEPES, pH 7.4, 0.5 M
NaCl. GST-tagged proteins were purified by affinity chromatography
using immobilized glutathione beads (Pierce) according to the manu-
facturer’s protocol, and the GST tag was on-column removed by Pre-
Scission protease (Amersham Biosciences). The C-terminal region of
mouse Coronin 1B (394–484 amino acids) was PCR cloned into pMAL-
c2g vector (New England Biolabs). Maltose-binding protein was puri-
fied by affinity chromatography using amylose resin (New England
Biolabs) according to the manufacturer’s protocol.
In Vitro Phosphorylation—2 g of recombinant protein was incu-
bated with 0.5 g of PKC (Panvera or Sigma) in 100 l of kinase
assay buffer (7.2 mM HEPES, pH 7.4, 3.6 mM MgCl2, 0.18 mM EGTA,
0.1% Triton X-100, 0.63 mM CaCl2, 0.1 M ATP, 0.5 M PMA, 120 M
phosphatidylserine) containing 10 Ci of [-32P]ATP for 30 min at 30 °C
(24). Reactions were terminated by adding an equal volume of 2
sample buffer. The samples were subjected to SDS-PAGE and trans-
ferred to a nitrocellulose membrane for autoradiography and peptide
mapping.
In Vivo Phosphorylation—Cells were serum starved for 12 h before
metabolic labeling, and then incubated with [32P]orthophosphoric acid
(Amersham Biosciences) in phosphate-free minimum essential medium
(Sigma). After 8 h, cells were treated with or without 100 nM PMA for
30 min and lysed with RIPA buffer (50 mM Tris-HCl, pH 7.3, 150 mM
NaCl, 1% IPEGAL, 0.5% deoxycholate, 1 mM EDTA, 1 mM phenylmeth-
ylsulfonyl fluoride, 10 g/ml 1,10-phenanthroline, 10 g/ml aprotinin,
10 g/ml leupeptin, 1 mM -naphthyl acid phosphate, 10 mM sodium
fluoride, and 2 mM sodium orthovanadate). The 13,000  g cleared
lysates were immunoprecipitated as described above. The immune com-
plexes were separated by SDS-PAGE and transferred to a nitrocellulose
membrane for autoradiography and peptide mapping.
Peptide Mapping—Peptide mapping was performed as described pre-
viously (25, 26). Briefly, appropriate protein bands were cut from the
nitrocellulose membrane and digested with L-1-tosylamido-2-phenyl-
ethyl chloromethyl ketone-treated trypsin (95%, 284 units/mg; Worth-
ington) in 0.05 M NH4HCO3, pH 7.8, at 37 °C for 24 h. The peptides were
washed and dried using a speed vacuum centrifuge, and spotted onto
cellulose thin layer chromatography plate (Merck KGaA, Germany) for
two-dimensional mapping using pH 8.9 buffer (ammonium carbonate,
10 g/liter) for electrophoresis in the first dimension and phosphochro-
matography buffer (n-butanol:pyridine:glacial acetic acid:deionized wa-
ter, 75:50:15:60) for chromatography in the second dimension. After
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that the thin layer chromatography plates were dried completely for
autoradiography.
Coro1B Antibody Production and Affinity Purification—Rabbits
were immunized with a GST fusion protein containing the human
Coronin 1B C-terminal region (394–489 amino acids) by Covance. Se-
rum was affinity purified against maltose-binding fusion protein con-
taining the equivalent region of mouse Coronin 1B to ensure cross-
reactivity. This myelin basic fusion protein was purified in a buffer
containing 10 mM MOPS, pH 7.5, and 60 mM sodium citrate, which was
used for direct coupling to UltraLink biosupport media (Pierce) accord-
ing to the manufacturer’s protocol. The column was washed extensively
with 10 mM Tris, pH 7.5, 100 mM glycine, pH 2.5, and 100 mM trieth-
ylamine, pH 11.5, with neutralizing washes between. Crude serum was
diluted 10-fold in 10 mM Tris, pH 7.5, and passed through the column
three times. The column was washed with 10 mM Tris, pH 7.5, and then
with 500 mM NaCl, 10 mM Tris, pH 7.5. Antibodies were eluted sequen-
tially with 100 mM glycine, pH 2.5, followed by 100 mM triethylamine,
pH 11.5. The antibody-containing fractions were neutralized, combined,
and dialyzed against phosphate-buffered saline.
Immunofluorescence Microscopy—For immunofluorescent staining,
the cells were fixed, stained, and mounted as described previously (23).
Cells were stained in various combinations with Alexa Fluor 568 phal-
loidin for F-actin (1:400 dilution), p34-Arc (1:400 dilution), or affinity
purified Coro1B antibody (1:200 dilution). Images were captured using
a Nipkow-type spinning disk confocal scan head (Yokogawa CSU-10)
attached to an inverted microscope (model IX-81, Olympus) equipped
with a 60 1.45 NA objective, a CCD camera (model C4742–80-12AG,
Hamamatsu), and controlled by AQM Advance 6 software (Kinetic
Imaging, Ltd.). The extended depth of focus plugin (bigwww.epfl.ch/
demo/edf/) for ImageJ was used to combine multiple images from a
z-stack (8 slices, 150 nm interval) into a single in-focus image. Images
were combined and annotated in Photoshop for presentation.
PMA-induced Ruffling Assay—To quantify ruffling, Rat2 cells were
serum-starved overnight, stimulated with 100 nM PMA, fixed at various
times as indicated, and stained with Alexa Fluor 568 phalloidin to
visualize membrane ruffles. At least 200 cells were counted for each
time point.
Single Cell Tracking—Tracking was performed as described previ-
ously (23). To increase data throughput, 10 different fields (containing
10–20 cells per field) were simultaneously recorded using an auto-
mated X-Y stage (Prior). To avoid bias in the analysis, every cell in each
movie that met the tracking criteria (did not divide, was completely
within the field of view for the entire experiment, and did not touch
another cell for more than two frames) was tracked using Tracking
Analysis software (Kinetic Imaging, Ltd.) with the point-click mode.
Cell speed was calculated using the Tracking Analysis software and
directional persistence was calculated using custom Matlab macros (a
kind gift of B. Harms, MIT). Data were analyzed using PRISM (Graph-
Pad, Inc.) for statistical analysis.
RESULTS
As a first step in understanding the role of mammalian
Coronins in cell motility, we used quantitative real-time PCR
to compare expression patterns of the genes across mouse tis-
sues. An advantage of this technique is the ability to quantita-
tively compare expression between genes, as well as across
tissues. Our data indicate that the most widely expressed
mammalian Coronin gene is CORONIN 1B, which is expressed
at high levels across most tissues (Fig. 1B). A full character-
ization of mammalian Coronin gene expression using this tech-
nique will be presented elsewhere.2 To study Coronin 1B at the
protein level, a polyclonal antibody was raised against the
unique region and the coiled-coil region of human Coronin 1B
(Fig. 1A). HEK293 cells were transient transfected with all six
Coronin genes tagged with GFP at the C terminus. The differ-
ent Coronins were enriched by immunoprecipitation (IP) using
a GFP antibody and blotted with the affinity purified Coro1B
antibody. This antibody specifically recognizes Coronin 1B and
does not cross-react with the other related Coronins (Fig. 1C).
Interestingly, the endogenous Coronin 1B was co-immunopre-
cipitated (co-IP) with Coronin 1B-GFP. The endogenous protein
was co-immunoprecipitated only from cells transfected with
Coronin 1B-GFP and not with any of the other Coronin con-
structs, suggesting only homo-oligomerization had occurred. To
confirm this result, we co-transfected cells with the complete
set of Coronin genes tagged with GFP and Coronin 1B-Myc.
Immunoprecipitation with a Myc antibody co-precipitated only
Coronin 1B-GFP and none of the other Coronins (Fig. 1D).
Together, these experiments strongly suggest that Coronin 1B
exclusively homo-oligomerizes and does not form complexes
with the other Coronins. Whereas other Coronins have been
shown to homo-oligomerize via their coiled-coil motif in vivo
(27), these data are the first to address the specificity of oli-
gomerization between members of this protein family.
To examine the localization of Coronin 1B, we used our
affinity purified antibody for immunofluorescent staining and
compared the localization of the endogenous protein to the
GFP-tagged form in Rat2 fibroblasts (Fig. 1E). Coronin 1B is
localized to the leading edge in fibroblasts, as well as weakly
along actin stress fibers. The localization of the GFP-tagged
form is indistinguishable from the endogenous protein. This
observation, along with the co-IP experiment described above,
suggests that Coronin 1B can tolerate tagging with GFP at the
C terminus.
In yeast, Coronin and the Arp2/3 complex biochemically and
genetically interact, but this interaction has not been demon-
strated in mammalian systems (6). To examine this interac-
tion, we first performed immunofluorescent co-localization be-
tween Coronin 1B and p34-Arc (a component of the Arp2/3
complex). These two proteins strongly and completely co-local-
ize at the leading edge of fibroblasts (Fig. 2A). To test for a
biochemical interaction between Coronin 1B and the Arp2/3
complex, we performed a reciprocal co-IP between Coronin 1B
and the p34-Arc subunit of the Arp2/3 complex. We saw a
robust, reciprocal co-IP between the endogenous Coronin 1B
and p34-Arc in Rat2 fibroblasts (Fig. 2B). This result was also
obtained in HEK293, Swiss 3T3, and NIH3T3 cells, suggesting
that this interaction is generally observed in many cell types
(data not shown). Control rabbit antibodies did not IP either
protein (Fig. 2, B and C). We also detected co-IP between
Coronin 1B and the Arp2 and p41Arc subunits of the Arp2/3
complex (data not shown), suggesting that our results are not
specific for p34-Arc, but reflect an interaction between Coronin
1B and the Arp2/3 complex. As an additional control, we were
also able to show co-IP between GFP-tagged Coronin 1B and
p34-Arc using GFP antibodies (Fig. 6B). We could not detect
actin in the immunocomplex by blotting, but to exclude the
possibility that this interaction is simply bridged through F-
actin, we pretreated cells with Latrunculin B to disrupt F-actin
prior to making the lysate for IP and saw no change in the
interaction (data not shown).
Because Coronins have been shown to be PKC substrates in
vitro and in vivo (12, 13), we tested whether phosphorylation
modulates the interaction between Coronin 1B and the Arp2/3
complex. With 100 nM PMA treatment, this interaction is
strongly decreased relative to untreated Rat2 cells (Fig. 2C). To
establish that the PMA stimulation was acting through a ki-
nase pathway, we used an anti-phosphoserine antibody raised
against a phosphopeptide corresponding to the PKC consensus
site. This antibody (pSerPKC) recognizes phosphorylated Coro-
nin 1B immunoprecipitated by our affinity purified Coro1B
antibody (Fig. 2C). Mutant analysis as described below con-
firmed the specificity of this antibody for phospho-Coronin 1B.
Further evidence for the specific involvement of PKC in regu-
lating Coronin 1B-Arp2/3 interactions comes from treatment
with two well established PKC inhibitors (28, 29). Pretreat-
ment of cells with a pan-PKC inhibitor (Ro32–0432) blocked2 L. Cai, N. Holoweckyj, and J. E. Bear, unpublished observations.
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PMA-stimulated phosphorylation of Coronin 1B and restored
the co-IP with p34-Arc. Interestingly, Gö6976 (which inhibits
the  and I isoforms of PKC) did not block phosphorylation or
restore co-IP of p34-Arc, suggesting that a novel isoform of PKC
(, , or ) may be responsible for the PMA-induced phosphoryl-
ation of Coronin 1B in vivo. Together, these experiments suggest
that the interaction between Coronin 1B and the Arp2/3 complex
is regulated through PKC phosphorylation of Coronin 1B.
Because the phosphorylation status of Coronin 1B is critical
for interaction with the Arp2/3 complex, we sought to identify
the residues that are phosphorylated in vivo. As a first step, we
did an in vitro kinase assay using purified PKC and His-tagged
FIG. 1. Expression, oligomerization, and localization of Coronin 1B. A, schematic diagram of Coronin 1B. B, quantitative heat map of
Coronin gene expression across mouse tissues using quantitative real-time PCR. Color scale indicates log10 value of the copy number of mRNA per
ng of total RNA for each Coronin gene based on cDNA standard curves derived as described under “Experimental Procedures.” C, homo-
oligomerization of Coronin 1B. HEK293 were transfected with the complete set of GFP-tagged Coronins, immunoprecipitated using a GFP
antibody, and blotted with GFP antibody or affinity purified Coronin 1B antibody. D, exclusive homo-oligomerization of Coronin 1B-GFP and
Coronin 1B-Myc. HEK293 cells were co-transfected with the complete set of GFP-tagged Coronin genes and Coronin 1B-Myc, immunoprecipitated
using a Myc antibody, and blotted for GFP or Myc. Asterisks indicate IgG heavy chain as a loading control. E, localization of GFP-tagged and
endogenous Coronin 1B in Rat2 fibroblasts. IB, immunoblotted.
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Coronin 1B. Recombinant Coronin 1B is strongly phosphoryl-
ated in this reaction (Fig. 3A). Similar results were obtained
using GST-tagged Coronin 1B (see below). As a positive control,
we used a fragment of vinculin that has been reported to be an
in vitro PKC substrate (24). Tryptic peptide mapping shows
that 4 to 5 sites on Coronin 1B are phosphorylated in vitro (Fig.
3B). To examine in vivo Coronin 1B phosphorylation, we im-
munoprecipitated GFP-tagged Coronin 1B from metabolically
labeled HEK293 cells. Upon PMA stimulation, Coronin 1B was
strongly phosphorylated (Fig. 3C). Tryptic peptide mapping
indicated that there is a single major site phosphorylated in
vivo (Fig. 3D).
Comparison of the in vitro and in vivo tryptic peptide maps
indicated that the in vivo site did not appear to match any of
the in vitro sites. We considered two possible explanations for
this observation: first, that PKC does not phosphorylate the
site in vitro that is utilized in vivo, or second, that the spot had
shifted because of an extra sequence on the peptide from the
His6 or GST tag. Comparison of the tryptic peptide maps of in
vivo phosphorylated Coronin 1B and in vitro phosphorylated
His1B or (GST)1B provide strong evidence for the latter possi-
bility. We used pairwise mixing of samples to compare the
maps of in vitro and in vivo phosphorylated proteins (Fig. 4,
A–D). Both the in vitro samples showed spots b, c, d, and e (Fig.
4C) that were absent in the in vivo labeled sample. Further-
more, we discovered that each sample contained a unique spot
(a, a, and a). It is important to note that, in the case of
(GST)1B, the N-terminal GST tag was removed by cleavage
prior to the phosphorylation reaction leaving five residual
amino acids. Because each sample has a unique N-terminal
tryptic peptide because of fusion of the His or GST tags (Fig.
4E), we postulated that a serine or threonine residue common
to all of these peptides, Ser-2 in the native protein, might be the
in vivo phosphorylated residue. Further evidence for this hy-
pothesis came from the predicted migration properties of the
N-terminal peptides. A theoretical peptide map of these pep-
tides, constructed based on established formulas for the rela-
tive migration of tryptic peptides, agreed with our experimen-
tal observations (Fig. 4F) (25).
To test the hypothesis that Ser-2 is the major in vivo phos-
phorylation site of Coronin 1B, this residue was mutated to
alanine in our GFP-tagged Coronin 1B construct and trans-
fected into HEK293 cells. This mutant, S2A, was immunopre-
cipitated from metabolically labeled cells stimulated with PMA
and subjected to peptide mapping (Fig. 5A). The prominent
phosphopeptide spot, a, was absent in the S2A sample, sug-
gesting that this is the major phosphorylation site in vivo. To
exclude the possibility that the Ser-2 mutation changes the
conformation of Coronin 1B and masks the actual phosphoryl-
ation site, we did an in vitro kinase assay on immunoprecipi-
tated wild type or S2A Coronin 1B-GFP from unlabeled
HEK293 cells (Fig. 5B). No phosphorylation was observed in
the absence of purified PKC, indicating that no endogenous
PKC was co-immunoprecipitated under these conditions. The
wild-type Coronin 1B-GFP showed a prominent band at the
FIG. 2. Coronin 1B interacts in vivo with the Arp2/3 complex in
a PKC phosphorylation-dependent manner. A, Coronin 1B co-
localization with the p34-Arc subunit of the Arp2/3 complex at the
leading edge of Rat2 fibroblasts. B, reciprocal co-immunoprecipitation
between endogenous Coronin 1B and p34-Arc in Rat2 cell lysates.
Rabbit IgG was used as a control for immunoprecipitation in panels B
and C. C, pharmacological modulation of interaction between Coronin
1B and p34-Arc. Upon PMA stimulation (100 nM), Coronin 1B is phos-
phorylated (pSerPKC blot) and the co-IP between Coronin 1B and the
Arp2/3 complex strongly decreases (p34-Arc blot). Both effects are
blocked by the pan-PKC inhibitor, Ro32-0432 (1 M), but not by Gö6976
(30 M), which inhibits only PKC and 1.
FIG. 3. Coronin 1B is robustly phosphorylated both in vitro
and in vivo. A, recombinant His-Coronin 1B is phosphorylated by
PKC in vitro (arrow). The phosphorylation of chicken vinculin tail (Vt;
amino acids 881–1135) served as a positive control. PKC autophos-
phorylation is indicated by the arrowhead. B, in vitro phosphorylated
His-Coronin 1B subjected to tryptic peptide mapping. The asterisk
indicates origin. Spots a–e showed a consistent pattern across multiple
experiments. C, GFP-tagged Coronin 1B was immunoprecipitated from
32P metabolically labeled HEK293 cells treated with and without 100
nM PMA (arrow indicates Coro1B-EGFP). D, tryptic peptide map of a
sample from C.
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correct molecular weight, whereas the S2A sample had no
detectable band at the equivalent area of the gel. These sam-
ples were blotted with our Coronin 1B antibody to confirm that
both proteins were present (data not shown). The tryptic pep-
tide maps generated from the Coronin 1B-GFP bands exhibited
a similar pattern of spots as the recombinant preparation stud-
ied previously (spots b–e). However, the wild-type sample did
not exhibit peptides a or a, but rather contained a peptide
corresponding to a. This spot was absent from the S2A sample
(Fig. 5C). Together, these data indicate that Ser-2 is the major
site phosphorylated by PKC on Coronin 1B in vivo.
Our experiments using PMA and PKC inhibitors demon-
strated that phosphorylation of Coronin 1B regulates its inter-
action with the Arp2/3 complex. If Ser-2 is the critical phospho-
rylation site, then mutations in Ser-2 should modulate the
Coronin 1B-Arp2/3 interaction. In addition to the S2A muta-
tion described above, we also made a second mutant, S2D, in
which Ser-2 was mutated to aspartic acid to mimic phospho-
rylated Coronin 1B. These mutants, along with the wild-type
version, were transiently expressed in HEK293 cells and im-
munoprecipitated with GFP antibodies. The IP samples were
blotted for p34-Arc to detect associated Arp2/3 complex. The
FIG. 4. Coronin 1B is phosphorylated on an N-terminal site. Tryptic peptide maps of (GST)1B (A), in vivo phosphorylated Coronin 1B (B),
a mixture of His1B  (GST)1B (C), and a mixture of His1B  in vivo sample (D). E, sequences of N-terminal tryptic peptides of the various samples.
Ser-2 is indicated with bold and italics. F, theoretical map of peptides from E.
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Coronin 1B S2A mutant showed a stronger interaction with the
Arp2/3 complex relative to wild type, whereas the S2D mutant
had weaker interaction (Fig. 6A). This trend is consistent with
our observation that increasing Coronin 1B phosphorylation by
PMA treatment decreases the interaction with Arp2/3. Inter-
estingly, these mutants did not affect oligomerization of the
GFP-tagged form with the endogenous Coronin 1B, suggesting
that this interaction is not regulated by phosphorylation at
Ser-2.
To further characterize these mutant versions of Coronin 1B,
we created stable Rat2 cell lines expressing the mutants via
retroviral transduction. These lines were sorted for equal levels
of GFP expression by a fluorescence-activated cell sorter, and
equal expression levels of Coronin 1B-GFP were verified by
Western blotting (Fig. 6B). We looked for changes in Coronin
1B-Arp2/3 interactions in these cell lines by co-IP. Unlike the
transiently transfected HEK293 cells, there was no increase in
the p34-Arc interaction with the S2A mutant, but there was a
reproducible decrease with the S2D mutant (Fig. 6C). When
these IPs were probed with the pSerPKC antibody described
above, we noted that the pSerPKC antibody does not cross-react
with either the S2A or S2D mutant (Fig. 6C). These data
demonstrate that this antibody specifically recognizes Coronin
1B phosphorylated on Ser-2. In cells expressing the S2A mu-
tant, we observed a hyperphosphorylation of the endogenous
Coronin 1B. This may reflect a compensatory mechanism in
this stable cell line. Because phospho-Coronin 1B does not
interact as well with Arp2/3, this may explain why we did not
observe an increase in p34-Arc interaction in the S2A-express-
ing cell line. When we examined the localization of the mutants
in these stable Rat2 lines, we saw no difference between either
of the mutant proteins and the wild type Coronin 1B-GFP.
There was also no discernable change in p34-Arc or F-actin
staining with expression of the mutants (Fig. 6B). This sug-
gests that phosphorylation of Coronin 1B does not affect its
subcellular localization properties, although it is formally pos-
sible that the mutants are localizing via oligomerization with
the endogenous Coronin 1B.
To address the importance of Ser-2 phosphorylation for Co-
ronin 1B function, we used a PMA-induced ruffle formation
assay. Previous studies indicated that PMA stimulation of se-
rum-starved cells induces a transient activation of the Rac
GTPase and that this Rac activity is required for PMA-induced
ruffling activity (30, 31). In our stable Rat2 lines expressing
wild-type or Ser-2-mutated Coronin 1B, we observed striking
differences in the ability of PMA to induce ruffles in serum-
starved cells (Table I). About 41% of the Rat2 control cells show
ruffling at 10 min after stimulation, whereas 60% of cells
overexpressing wild-type Coronin 1B show ruffling under the
same conditions. Both the Rat2 control cells and wild-type
Coronin 1B overexpressers had diminished ruffling by 30 min
after stimulation, suggesting that this response adapts over
time. Cells expressing the S2A mutant version of Coronin 1B
had the highest level of ruffling (71%) at 10 min and had
sustained high levels of ruffling at all time points tested. In-
terestingly, cells expressing the S2D mutant version of Coronin
1B had suppressed ruffling with only about 26% of cells show-
ing ruffling activity at 10 min. The S2D cells did show a peak
of ruffling activity at 20 min that returned to control levels by
30 min, suggesting that these cells have diminished ruffling
rather than a total loss. Together, these data suggest that
overexpression of wild-type or S2A Coronin 1B enhances the
early phase of the ruffling response, and that Coronin 1B
phosphorylation at Ser-2 may be a major factor in the adapta-
tion of PMA-induced ruffling at later times. Furthermore, these
data suggest that, consistent with its localization pattern, Co-
ronin 1B exerts a strong effect on actin-dependent processes at
the leading edge.
To further explore Coronin 1B function and the role of Ser-2
phosphorylation in regulating Coronin function, we turned to
the single cell tracking assay. In this assay, individual cells
undergoing random cell movement are tracked in time-lapse
movies and information about speed and directional persist-
ence are extracted. Overexpression of wild-type Coronin 1B
caused a slight, but statistically significant increase in average
cell speed (analysis of variance, F  106.7, p  0.0001; Dun-
nett’s multiple comparison test, p  0.05) (Fig. 7A). Expression
of the S2A mutant caused a much stronger increase in cell
speed, whereas expression of the S2D mutant suppressed cell
speed below that of the parental Rat2 cells (Dunnett’s multiple
comparison test, p  0.01). None of the cell lines showed sig-
nificant differences in directional persistence (data not shown).
To understand the relative contribution of Ser-2 phosphoryl-
ation to the overall effect of PMA on cell migration, we first
examined the dose relationship of PMA treatment to Coronin
1B phosphorylation by Western blotting. In this experiment,
the cells were treated with PMA for 30 min in serum-contain-
ing media. For examining phosphorylation status, we used
Rat2 cells expressing wild-type Coronin 1B tagged with GFP to
FIG. 5. Ser-2 of Coronin 1B is the site directly phosphorylated
by PKC in vivo. A, in vivo phosphorylation of either wild-type (WT) or
S2A mutant form of Coronin 1B expressed in HEK293 cells, and stim-
ulated with 100 nM PMA. B, in vitro phosphorylation of immunopre-
cipitated wild-type or S2A mutant Coronin 1B tagged with GFP from
unlabeled HEK293 cells by purified PKC. Arrow indicates GFP-tagged
Coronin and the arrowhead indicates PKC autophosphorylation. C,
tryptic peptide maps of GFP-tagged Coronins from B. Note the similar
pattern of b, c, d, and e spots to in vitro samples from Fig. 4 and absence
of the a spot in S2A mutant. Equal counts of both the wild-type and
S2A samples were loaded on the TLC plates to reveal any detectable
phosphorylation of peptide a in the S2A sample.
Coronin-Arp2/3 Interaction Regulated by PKC 31919
examine the phosphorylation of both the GFP-tagged and en-
dogenous forms. Cells were stimulated with different doses of
PMA and the Coronin 1B-GFP immunoprecipitated with GFP
antibodies. These samples were blotted either with the pSerPKC
antibody to detect phosphorylated Coronin 1B or the Coronin
1B antibody to detect total immunoprecipitated Coronin pro-
tein (Fig. 7B). Both GFP-tagged and endogenous Coronin 1B
are phosphorylated in a dose-dependent manner with the
greatest increase occurring between 1 and 5 nM PMA.
To address the importance of Ser-2 phosphorylation in me-
diating the effects on cell migration on PMA, we did a dose-
response single cell tracking experiment in our cell lines ex-
pressing the wild-type or mutant forms of Coronin 1B (Fig. 7C).
For Rat2 control cells, a steady decrease in cell speed was
observed with increasing PMA dose. This is consistent with
studies of other cells lines showing an inhibitory effect of PMA
on cell speed (32). Cells overexpressing the wild-type Coronin
1B showed a similar overall dose-dependent decrease in cell
speed, but showed a sharper drop between 1 and 5 nM PMA
relative to controls. This is consistent with the phospho-specific
FIG. 6. Ser-2 mutants affect the interaction between Coronin 1B and the Arp2/3 complex, but not subcellular localization. A,
transient transfection of Ser-2 mutants into HEK293 cells. Samples were immunoprecipitated with GFP antibody and blotted with Coro1B or
p34-Arc antibodies. The arrowhead indicates GFP-tagged Coronin 1B, and the arrow indicates endogenous Coronin 1B. B, lysates from Rat2 stable
cell lines expressing GFP-tagged wild-type, S2A, or S2D mutant Coronin 1B blotted as indicated. C, GFP IPs of samples in B blotted as indicated.
Note the lack of cross-reactivity of pSerPKC antibody with either Ser-2 mutant. D, GFP-tagged Ser-2 mutants have the same localization pattern
as the wild-type Coronin 1B in Rat2 cells. Cells were stained with antibodies to p34-Arc to label Arp2/3 and phalloidin to label F-actin.
TABLE I
PMA-induced ruffling response
Data presented are the combined results from two independent experiments. Cells were counted in 6 fields of view with ruffling cells/total, cells
counted are reported in parentheses. Chi-square values for each time point range from 38.5 to 82.9, indicating that each time point contains
statically significant deviation from expected Rat2 control proportion (p  0.000001).
Untreated 5 min 10 min 20 min 30 min
Rat2 13.4% (46/343) 38.4% (159/414) 41.4% (165/399) 52.2% (224/429) 38.8% (150/387)
WT1B 30.1% (64/213) 55.4% (185/334) 60.3% (188/312) 64.2% (280/436) 47.0% (236/502)
S2A 17.8% (40/225) 63.3% (209/330) 71.3% (268/376) 76.1% (331/435) 76.1% (299/393)
S2D 25.4% (63/248) 13.2% (38/287) 26.8% (110/410) 45.0% (172/382) 32.8% (168/513)
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Western blot analysis where the sharpest increase in phospho-
rylation occurred between these two doses. Cells expressing the
S2A mutant showed a dose-dependent decrease in cell speed to
a point, but the decline in cell speed leveled off by 5 nM and
showed no further decrease after this point. This suggests that
a mutant version of Coronin 1B that cannot be phosphorylated
confers partial resistance to the inhibitory effects of PMA on
cell speed. Conversely, the S2D mutant rendered the cells
hypersensitive to the inhibitory effects of PMA with the major-
ity of the inhibitory effect occurring by the 5 nM dose. Together,
these data indicate that Coronin 1B phosphorylation at Ser-2
plays a significant role in mediating the effects of PMA on cell
migration speed in fibroblasts.
DISCUSSION
Coronins are a highly conserved family of proteins that reg-
ulate actin-dependent processes such as migration and endo-
cytosis; however, little is known about the function or regula-
tion of these molecules in mammalian systems. In this work,
we show that Coronin 1B interacts in vivo with the Arp2/3
complex and that this interaction is inhibited by PKC phospho-
rylation. We have identified the single major in vivo phospho-
rylation site, Ser-2, and demonstrated that mutations in this
site cause striking effects on fibroblast motility. In addition, we
show that Coronin 1B phosphorylation mediates a significant
fraction of PMA-induced changes in fibroblast motility.
Mammalian genomes contain at least six Coronin genes that
can be broken down into three subclasses based on sequence
homology, localization, and function.2 Coronins 1A, 1B, and 1C
form a distinct group and are most similar to the Coronin genes
in single-cell eukaryotes. The Coronin 1B and 1C genes are
ubiquitously expressed, but Coronin 1B is expressed at 2–10-
fold higher levels at the mRNA level depending on the tissue.
This suggests that Coronin 1B may the predominant Coronin of
this subclass in many cell types and tissues.
Because Coronin 1B is expressed at such high levels across
tissues, we examined a number of molecular interactions that
have been seen with other Coronins for this protein. First, our
data show that Coronin 1B oligomerizes with itself and that
this interaction is exclusively homo-oligomeric in nature. It will
be interesting to see if all mammalian Coronins display this
degree of specificity in their oligomerization. Second, like all
other Coronins tested from any species, recombinant Coronin
1B co-sediments with F-actin in vitro.2 Third, our reciprocal
co-IP and co-localization data show that Coronin 1B interacts
in vivo with the Arp2/3 complex in all cell types tested. Fur-
thermore, we see similar interactions between Coronin 1C and
Arp2/3.3 Whereas Coronin 1A was identified as a major co-
purifying protein in preparations of the Arp2/3 complex from
neutrophils, the data reported in this work are the first to
directly confirm that the Coronin-Arp2/3 interaction, first dem-
3 N. Holoweckyj and J. E. Bear, unpublished observation.
FIG. 7. Phosphorylation of Coronin
1B at Ser-2 regulates cell migration.
A, migration speed of Rat2 stable cell
lines measured by the single cell tracking
method (number tracked per cell type in
parentheses). Data were analyzed by one-
way analysis of variance (p  0.0001), and
individual treatments were analyzed with
Dunnett’s multiple comparison post-test
(*, p  0.05; **, p  0.01; error bars show
95% confidence intervals). B, PMA in-
duces a dose-dependent increase in Coro-
nin 1B phosphorylation. Rat2 cells ex-
pressing the GFP-tagged wild-type
Coronin 1B were treated with the indi-
cated dose of PMA for 30 min. Lysates
were immunoprecipitated with GFP anti-
bodies and blotted as indicated. The ar-
rowhead indicates GFP-tagged Coronin
1B, and the arrow indicates endogenous
Coronin 1B. C, migration speeds of Rat2
stable cell lines treated with different
doses of PMA. Cells were treated with
PMA for 30 min prior to the beginning of
the movies and drug was present
throughout. Speed was measured by the
single cell tracking method (at least 100
cells tracked for each data point).
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onstrated in yeast, is conserved in mammals.
Our data are the first direct demonstration that phosphoryl-
ation regulates Coronin function. Other groups have reported
PKC phosphorylation of Coronins 1A and 1B and, for Coronin
1A, there is an increased localization of the protein on phago-
somes in HL-60 cells treated with high doses of PKC inhibitors,
but none of these studies directly shows regulation by phospho-
rylation (12, 13). Our studies reveal that the in vivo interaction
between Coronin 1B and Arp2/3 is strongly inhibited by PKC
phosphorylation. We mapped the major in vivo PKC phospho-
rylation site on Coronin 1B to Ser-2 using tryptic peptide anal-
ysis and confirmed this result using site-directed mutagenesis.
Expressing Ser-2 mutants has striking effects on fibroblast
motility. The S2A mutant has stronger interaction with Arp2/3,
and increases PMA-induced ruffling and cell speed relative to
the wild-type Coronin 1B, suggesting that this mutant is con-
stitutively active. Conversely, the S2D mutant has reduced
interaction with Arp2/3, inhibits ruffling, and suppresses cell
speed below that of the parental Rat2 cells, suggesting that this
mutation creates a dominant negative Coronin.
Although our data shows regulation of Coronin function by
PKC, several outstanding issues remain to be resolved. The
precise isoform or isoforms of PKC that phosphorylate Coronin
1B in vivo remain to be delineated. Furthermore, the upstream
signaling pathways that ultimately regulate Coronin 1B phos-
phorylation also remain unclear. In rabbit parietal cells, car-
bachol (a muscarinic agonist) stimulates Coronin 1B phospho-
rylation (13), but we were unable to stimulate Coronin 1B
phosphorylation in HEK293 cells with this agonist (data not
shown). However, this may simply reflect poor/absent expres-
sion of the necessary receptor or G-protein in this cell type. A
second unresolved issue concerning the PKC regulation of Co-
ronin 1B function is the nature of the dominant negative effect
observed with the S2D mutant. At least two possible explana-
tions could account for this effect. First, this pseudo-phospho-
rylated version may be non-functional, but still able to bind to
and sequester key Coronin 1B binding partners. Second, phos-
pho-Coronin 1B may have a distinct function from the dephos-
pho-form that does not involve Arp2/3 and is inhibitory for
ruffling and migration. More experiments will be needed to
resolve these issues.
Whereas the mechanistic details of mammalian Coronin
function remain unclear, it is worth considering data on Coro-
nin function from yeast in developing a working hypothesis
about Coronin 1B function in mammalian cell motility. In
yeast, Coronin binds directly to the Arp2/3 complex in vitro
and, more specifically, to the p35-Arc subunit in two-hybrid
assays (6). When added to in vitro polymerization assays, Co-
ronin inhibits the Arp2/3-mediated nucleation of actin fila-
ments. Recent structural data indicate that the addition of
Coronin to Arp2/3 preparations (visualized by EM and single
particle reconstruction) causes Arp2/3 to adopt an open or
inactive conformation (33). Together, these data led the Goode
laboratory (33) to propose that yeast Coronin is a direct inhib-
itor of the Arp2/3 complex. Our data indicate that overexpres-
sion of the mutant form of Coronin 1B (S2A) that interacts
more robustly with Arp2/3 drives the actin-dependent pro-
cesses of membrane ruffling and cell migration.
Superficially, these datasets seem inconsistent, but there are
a number of possible models in which both could be correct or at
least consistent within a particular cellular context. One pos-
sibility is that Coronin inhibits Arp2/3 activity in both yeast
and mammalian cells, but that in fibroblasts, this results (in-
directly) in the disassembly of actin networks through other
mechanisms such as ADF/cofilin. This would result in acceler-
ated actin network turnover, and that could lead to enhanced
cell motility. Such a mechanism would be consistent with the
genetic synergy between mutations in the Coronin and Cofilin
genes in yeast (5). Another possibility is that Coronin recruits
inactive Arp2/3 to the sides of actin filaments at specific loca-
tions within cells where it can be acted upon by activators such
SCAR/WASP proteins as previously suggested (6). Phosphoryl-
ation of Coronin (and subsequent loss of interaction with
Arp2/3) could act as a switch to expose “activable” Arp2/3 that
had been previously docked on filaments at specific locations
within the cell. Neither of these models, however, completely
explains why Coronin is a biochemical inhibitor of Arp2/3, but
a cellular “activator” of Arp2/3-dependent processes such as
membrane ruffling and cell migration in fibroblasts. Alter-
nately, mammalian Coronins and yeast Coronin may both in-
teract with Arp2/3, but have evolved divergent mechanisms for
regulating the complex. Experiments are underway to rigor-
ously test these and other possible models.
One of our most striking findings is that Coronin 1B phos-
phorylation mediates a significant fraction of effects of PMA on
fibroblast ruffling and migration. This is a somewhat surpris-
ing result because PMA activates all of the conventional and
novel isoforms of PKC, and likely stimulates the phosphoryla-
tion of a large number of protein substrates. When considering
our results with PMA, it is important to take into account the
precise conditions of treatment and the different phenomenon
being observed. The PMA-induced ruffling is highly dependent
on serum starvation and may represent a different effect than
the 2–3-h treatments in the presence of serum that we used for
the cell tracking studies. Our ruffling data are consistent with
Coronin 1B playing at least two distinct roles in this process.
First, overexpression of wild-type (or S2A) Coronin 1B en-
hances the PMA-induced ruffling response that is initiated by
an unknown PMA target and presumably involves a Rac-de-
pendent pathway. Second, subsequent phosphorylation of Co-
ronin 1B appears to be critical for an adaptation of the PMA-
induced ruffling response as demonstrated by the sustained
ruffling observed in the cells expressing the S2A mutant. In the
cell tracking experiments, PMA was added 30 min before the
start of the movies in the presence of serum. This treatment did
not induce continuous ruffling, but rather seemed to cause a
dose-dependent reduction of the polarized morphology nor-
mally seen in migrating fibroblasts. The reduction in cell speed
likely arises from the failure to maintain the polarized mor-
phology necessary for effective migration. Expression of the
S2A mutant version of Coronin 1B partially protected the cells
from this loss of polarity induced by PMA (data not shown).
This suggests that, in this assay, Coronin 1B phosphorylation
may have an important role in regulating cell polarity. Future
experiments will explicitly test this hypothesis.
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